Global Adoptive Cell Therapy Market Research Report 2022 - Market Study Report

Global Adoptive Cell Therapy Market Research Report 2022

Report Format: PDF | Report ID: 5378899 | Published Date: July 22, 2022

Choose License
Adoptive Cell Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Adoptive Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    CAR-T
    TCR-T
    NK
    TIL
Segment by Application
    Lymphoma
    Leukemia
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Novartis
    Juno
    Kite
    Adaptimmune
    Fibrocell
    Lineage Cell Therapeutics
    BioTime
    Vericel Corporation
    Regeneus
    Anhui Anke Biotechnology
    Cellectis
    NantKwest
    SorrentoTherapeutics
    Bellicum
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Adoptive Cell Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 CAR-T
        1.2.3 TCR-T
        1.2.4 NK
        1.2.5 TIL
    1.3 Market by Application
        1.3.1 Global Adoptive Cell Therapy Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Lymphoma
        1.3.3 Leukemia
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Adoptive Cell Therapy Market Perspective (2017-2028)
    2.2 Adoptive Cell Therapy Growth Trends by Region
        2.2.1 Adoptive Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Adoptive Cell Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Adoptive Cell Therapy Forecasted Market Size by Region (2023-2028)
    2.3 Adoptive Cell Therapy Market Dynamics
        2.3.1 Adoptive Cell Therapy Industry Trends
        2.3.2 Adoptive Cell Therapy Market Drivers
        2.3.3 Adoptive Cell Therapy Market Challenges
        2.3.4 Adoptive Cell Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Adoptive Cell Therapy Players by Revenue
        3.1.1 Global Top Adoptive Cell Therapy Players by Revenue (2017-2022)
        3.1.2 Global Adoptive Cell Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Adoptive Cell Therapy Revenue
    3.4 Global Adoptive Cell Therapy Market Concentration Ratio
        3.4.1 Global Adoptive Cell Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Therapy Revenue in 2021
    3.5 Adoptive Cell Therapy Key Players Head office and Area Served
    3.6 Key Players Adoptive Cell Therapy Product Solution and Service
    3.7 Date of Enter into Adoptive Cell Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Adoptive Cell Therapy Breakdown Data by Type
    4.1 Global Adoptive Cell Therapy Historic Market Size by Type (2017-2022)
    4.2 Global Adoptive Cell Therapy Forecasted Market Size by Type (2023-2028)
5 Adoptive Cell Therapy Breakdown Data by Application
    5.1 Global Adoptive Cell Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Adoptive Cell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Adoptive Cell Therapy Market Size (2017-2028)
    6.2 North America Adoptive Cell Therapy Market Size by Country (2017-2022)
    6.3 North America Adoptive Cell Therapy Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Adoptive Cell Therapy Market Size (2017-2028)
    7.2 Europe Adoptive Cell Therapy Market Size by Country (2017-2022)
    7.3 Europe Adoptive Cell Therapy Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Adoptive Cell Therapy Market Size (2017-2028)
    8.2 Asia-Pacific Adoptive Cell Therapy Market Size by Country (2017-2022)
    8.3 Asia-Pacific Adoptive Cell Therapy Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Adoptive Cell Therapy Market Size (2017-2028)
    9.2 Latin America Adoptive Cell Therapy Market Size by Country (2017-2022)
    9.3 Latin America Adoptive Cell Therapy Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Adoptive Cell Therapy Market Size (2017-2028)
    10.2 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2017-2022)
    10.3 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Novartis
        11.1.1 Novartis Company Detail
        11.1.2 Novartis Business Overview
        11.1.3 Novartis Adoptive Cell Therapy Introduction
        11.1.4 Novartis Revenue in Adoptive Cell Therapy Business (2017-2022)
        11.1.5 Novartis Recent Development
    11.2 Juno
        11.2.1 Juno Company Detail
        11.2.2 Juno Business Overview
        11.2.3 Juno Adoptive Cell Therapy Introduction
        11.2.4 Juno Revenue in Adoptive Cell Therapy Business (2017-2022)
        11.2.5 Juno Recent Development
    11.3 Kite
        11.3.1 Kite Company Detail
        11.3.2 Kite Business Overview
        11.3.3 Kite Adoptive Cell Therapy Introduction
        11.3.4 Kite Revenue in Adoptive Cell Therapy Business (2017-2022)
        11.3.5 Kite Recent Development
    11.4 Adaptimmune
        11.4.1 Adaptimmune Company Detail
        11.4.2 Adaptimmune Business Overview
        11.4.3 Adaptimmune Adoptive Cell Therapy Introduction
        11.4.4 Adaptimmune Revenue in Adoptive Cell Therapy Business (2017-2022)
        11.4.5 Adaptimmune Recent Development
    11.5 Fibrocell
        11.5.1 Fibrocell Company Detail
        11.5.2 Fibrocell Business Overview
        11.5.3 Fibrocell Adoptive Cell Therapy Introduction
        11.5.4 Fibrocell Revenue in Adoptive Cell Therapy Business (2017-2022)
        11.5.5 Fibrocell Recent Development
    11.6 Lineage Cell Therapeutics
        11.6.1 Lineage Cell Therapeutics Company Detail
        11.6.2 Lineage Cell Therapeutics Business Overview
        11.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Introduction
        11.6.4 Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2017-2022)
        11.6.5 Lineage Cell Therapeutics Recent Development
    11.7 BioTime
        11.7.1 BioTime Company Detail
        11.7.2 BioTime Business Overview
        11.7.3 BioTime Adoptive Cell Therapy Introduction
        11.7.4 BioTime Revenue in Adoptive Cell Therapy Business (2017-2022)
        11.7.5 BioTime Recent Development
    11.8 Vericel Corporation
        11.8.1 Vericel Corporation Company Detail
        11.8.2 Vericel Corporation Business Overview
        11.8.3 Vericel Corporation Adoptive Cell Therapy Introduction
        11.8.4 Vericel Corporation Revenue in Adoptive Cell Therapy Business (2017-2022)
        11.8.5 Vericel Corporation Recent Development
    11.9 Regeneus
        11.9.1 Regeneus Company Detail
        11.9.2 Regeneus Business Overview
        11.9.3 Regeneus Adoptive Cell Therapy Introduction
        11.9.4 Regeneus Revenue in Adoptive Cell Therapy Business (2017-2022)
        11.9.5 Regeneus Recent Development
    11.10 Anhui Anke Biotechnology
        11.10.1 Anhui Anke Biotechnology Company Detail
        11.10.2 Anhui Anke Biotechnology Business Overview
        11.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Introduction
        11.10.4 Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2017-2022)
        11.10.5 Anhui Anke Biotechnology Recent Development
    11.11 Cellectis
        11.11.1 Cellectis Company Detail
        11.11.2 Cellectis Business Overview
        11.11.3 Cellectis Adoptive Cell Therapy Introduction
        11.11.4 Cellectis Revenue in Adoptive Cell Therapy Business (2017-2022)
        11.11.5 Cellectis Recent Development
    11.12 NantKwest
        11.12.1 NantKwest Company Detail
        11.12.2 NantKwest Business Overview
        11.12.3 NantKwest Adoptive Cell Therapy Introduction
        11.12.4 NantKwest Revenue in Adoptive Cell Therapy Business (2017-2022)
        11.12.5 NantKwest Recent Development
    11.13 SorrentoTherapeutics
        11.13.1 SorrentoTherapeutics Company Detail
        11.13.2 SorrentoTherapeutics Business Overview
        11.13.3 SorrentoTherapeutics Adoptive Cell Therapy Introduction
        11.13.4 SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2017-2022)
        11.13.5 SorrentoTherapeutics Recent Development
    11.14 Bellicum
        11.14.1 Bellicum Company Detail
        11.14.2 Bellicum Business Overview
        11.14.3 Bellicum Adoptive Cell Therapy Introduction
        11.14.4 Bellicum Revenue in Adoptive Cell Therapy Business (2017-2022)
        11.14.5 Bellicum Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Adoptive Cell Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of CAR-T Table 3. Key Players of TCR-T Table 4. Key Players of NK Table 5. Key Players of TIL Table 6. Global Adoptive Cell Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Adoptive Cell Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Adoptive Cell Therapy Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Adoptive Cell Therapy Market Share by Region (2017-2022) Table 10. Global Adoptive Cell Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Adoptive Cell Therapy Market Share by Region (2023-2028) Table 12. Adoptive Cell Therapy Market Trends Table 13. Adoptive Cell Therapy Market Drivers Table 14. Adoptive Cell Therapy Market Challenges Table 15. Adoptive Cell Therapy Market Restraints Table 16. Global Adoptive Cell Therapy Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Adoptive Cell Therapy Market Share by Players (2017-2022) Table 18. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2021) Table 19. Ranking of Global Top Adoptive Cell Therapy Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Adoptive Cell Therapy Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Adoptive Cell Therapy Product Solution and Service Table 23. Date of Enter into Adoptive Cell Therapy Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Adoptive Cell Therapy Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Adoptive Cell Therapy Revenue Market Share by Type (2017-2022) Table 27. Global Adoptive Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Adoptive Cell Therapy Revenue Market Share by Type (2023-2028) Table 29. Global Adoptive Cell Therapy Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Adoptive Cell Therapy Revenue Market Share by Application (2017-2022) Table 31. Global Adoptive Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Adoptive Cell Therapy Revenue Market Share by Application (2023-2028) Table 33. North America Adoptive Cell Therapy Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Adoptive Cell Therapy Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Adoptive Cell Therapy Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Adoptive Cell Therapy Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Adoptive Cell Therapy Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Adoptive Cell Therapy Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Adoptive Cell Therapy Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Adoptive Cell Therapy Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Adoptive Cell Therapy Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Adoptive Cell Therapy Market Size by Country (2023-2028) & (US$ Million) Table 43. Novartis Company Detail Table 44. Novartis Business Overview Table 45. Novartis Adoptive Cell Therapy Product Table 46. Novartis Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million) Table 47. Novartis Recent Development Table 48. Juno Company Detail Table 49. Juno Business Overview Table 50. Juno Adoptive Cell Therapy Product Table 51. Juno Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million) Table 52. Juno Recent Development Table 53. Kite Company Detail Table 54. Kite Business Overview Table 55. Kite Adoptive Cell Therapy Product Table 56. Kite Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million) Table 57. Kite Recent Development Table 58. Adaptimmune Company Detail Table 59. Adaptimmune Business Overview Table 60. Adaptimmune Adoptive Cell Therapy Product Table 61. Adaptimmune Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million) Table 62. Adaptimmune Recent Development Table 63. Fibrocell Company Detail Table 64. Fibrocell Business Overview Table 65. Fibrocell Adoptive Cell Therapy Product Table 66. Fibrocell Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million) Table 67. Fibrocell Recent Development Table 68. Lineage Cell Therapeutics Company Detail Table 69. Lineage Cell Therapeutics Business Overview Table 70. Lineage Cell Therapeutics Adoptive Cell Therapy Product Table 71. Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million) Table 72. Lineage Cell Therapeutics Recent Development Table 73. BioTime Company Detail Table 74. BioTime Business Overview Table 75. BioTime Adoptive Cell Therapy Product Table 76. BioTime Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million) Table 77. BioTime Recent Development Table 78. Vericel Corporation Company Detail Table 79. Vericel Corporation Business Overview Table 80. Vericel Corporation Adoptive Cell Therapy Product Table 81. Vericel Corporation Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million) Table 82. Vericel Corporation Recent Development Table 83. Regeneus Company Detail Table 84. Regeneus Business Overview Table 85. Regeneus Adoptive Cell Therapy Product Table 86. Regeneus Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million) Table 87. Regeneus Recent Development Table 88. Anhui Anke Biotechnology Company Detail Table 89. Anhui Anke Biotechnology Business Overview Table 90. Anhui Anke Biotechnology Adoptive Cell Therapy Product Table 91. Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million) Table 92. Anhui Anke Biotechnology Recent Development Table 93. Cellectis Company Detail Table 94. Cellectis Business Overview Table 95. Cellectis Adoptive Cell TherapyProduct Table 96. Cellectis Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million) Table 97. Cellectis Recent Development Table 98. NantKwest Company Detail Table 99. NantKwest Business Overview Table 100. NantKwest Adoptive Cell TherapyProduct Table 101. NantKwest Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million) Table 102. NantKwest Recent Development Table 103. SorrentoTherapeutics Company Detail Table 104. SorrentoTherapeutics Business Overview Table 105. SorrentoTherapeutics Adoptive Cell TherapyProduct Table 106. SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million) Table 107. SorrentoTherapeutics Recent Development Table 108. Bellicum Company Detail Table 109. Bellicum Business Overview Table 110. Bellicum Adoptive Cell TherapyProduct Table 111. Bellicum Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million) Table 112. Bellicum Recent Development Table 113. Research Programs/Design for This Report Table 114. Key Data Information from Secondary Sources Table 115. Key Data Information from Primary Sources List of Figures Figure 1. Global Adoptive Cell Therapy Market Share by Type: 2021 VS 2028 Figure 2. CAR-T Features Figure 3. TCR-T Features Figure 4. NK Features Figure 5. TIL Features Figure 6. Global Adoptive Cell Therapy Market Share by Application in 2021 & 2028 Figure 7. Lymphoma Case Studies Figure 8. Leukemia Case Studies Figure 9. Adoptive Cell Therapy Report Years Considered Figure 10. Global Adoptive Cell Therapy Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Adoptive Cell Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Adoptive Cell Therapy Market Share by Region: 2021 VS 2028 Figure 13. Global Adoptive Cell Therapy Market Share by Players in 2021 Figure 14. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Adoptive Cell Therapy Revenue in 2021 Figure 16. North America Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Adoptive Cell Therapy Market Share by Country (2017-2028) Figure 18. United States Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Adoptive Cell Therapy Market Share by Country (2017-2028) Figure 22. Germany Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Adoptive Cell Therapy Market Share by Region (2017-2028) Figure 30. China Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Adoptive Cell Therapy Market Share by Country (2017-2028) Figure 38. Mexico Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Adoptive Cell Therapy Market Share by Country (2017-2028) Figure 42. Turkey Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Novartis Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022) Figure 45. Juno Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022) Figure 46. Kite Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022) Figure 47. Adaptimmune Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022) Figure 48. Fibrocell Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022) Figure 49. Lineage Cell Therapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022) Figure 50. BioTime Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022) Figure 51. Vericel Corporation Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022) Figure 52. Regeneus Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022) Figure 53. Anhui Anke Biotechnology Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022) Figure 54. Cellectis Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022) Figure 55. NantKwest Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022) Figure 56. SorrentoTherapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022) Figure 57. Bellicum Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research

Budget constraint? Get in touch to get special pricing offers


Request For Discount

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support

Can't find what you're looking for about this report?

Submit Query

Go to contact form

Phone Number

1-302-273-0910
Chat with us